Watson Laboratories, Inc. (WPI) and Andrx Corporation (ADRX) Confirms OxyContin(R) Patent Challenge; Filed ANDA
3/28/2011 11:04:40 AM
More...
|
ACCU-BREAK Pharmaceuticals, Inc. Announces Appointment Of Lawrence Rosenthal, Former President Of Andrx Pharmaceuticals, Inc.
11/30/2006 11:24:37 AM
More...
|
Shire Pharmaceuticals Group plc (SHPGY) Sues Andrx Corporation (ADRX)
11/10/2006 1:15:27 PM
More...
|
Watson Pharmaceuticals, Inc. (WPI) Completes Acquisition Of Andrx Corporation (ADRX)
11/7/2006 10:31:43 AM
More...
|
Watson Pharmaceuticals, Inc. (WPI) Receives FTC Clearance For Andrx Corporation (ADRX) Acquisition
11/1/2006 10:17:44 AM
More...
|
Andrx Corporation (ADRX) Certifies To The Satisfaction Of Certain Conditions To Closing Acquisition By Watson Pharmaceuticals, Inc. (WPI)
9/13/2006 12:19:35 PM
More...
|
Andrx Corporation (ADRX) Reports Financial Results For 2006 Second Quarter
8/9/2006 12:47:52 PM
More...
|
Watson Pharmaceuticals, Inc. (WPI) And Andrx Corporation (ADRX) Amend Merger Agreement
7/10/2006 1:08:39 PM
More...
|
Andrx Corporation (ADRX) Reports Financial Results For 2006 First Quarter
5/5/2006 1:43:35 PM
More...
|
Watson Pharmaceuticals, Inc. (WPI) And Andrx Corporation (ADRX) Receive FTC Second Request
5/3/2006 10:47:23 AM
More...
|
|